Immatics N.V.
IMTXNASDAQHealthcareBiotechnology
As of Oct 26, 2026 close
- Market cap
- $977.26M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $6.65$12.41
- Volume (live)
- -
- Avg. volume (3M)
- 959.26K
Immatics (IMTX) Stock Price & Financial Analysis
Immatics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $7.03 - $7.73 |
|---|---|
| 52-Week High | $12.41 |
| 52-Week Low | $6.65 |
| Open | $7.55 |
| Volume (last close) | 756.09K |
| Average Volume (3M) | 959.26K |
| Revenue (TTM) | 46.58M |
|---|---|
| Net Income (TTM) | -230.68M |
| Free Cash Flow (TTM) | -234.04M |
| EPS (TTM) | −$1.78 |
| Profit Margin | -495.27% |
| Operating Margin | -543.79% |
| Return on Equity (ROE) | -51.71% |
| Debt to Equity | 0.04 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 977.26M |
|---|---|
| Shares Outstanding | 136.68M |
| Price to Sales (P/S) | 20.98 |
| Price to Book (P/B) | 2.19 |
| EV/EBITDA | -3.47 |
| 50-Day MA | $8.57 |
|---|---|
| 200-Day MA | $9.68 |
| 1-Year Change | −25.93% |
Source: Market prices and company fundamentals. Data as of Oct 26, 2026. Data sources and methodology
Immatics at a Glance
As of the Oct 26, 2026 close, Immatics (IMTX) has a market capitalization of $977.26M. The stock trades at 21.0× sales. Over the trailing twelve months it lost $230.68M on revenue of $46.58M and burned $234.04M of free cash flow. Revenue fell 68.0% year over year.
As of its latest reported balance sheet, it holds $259.51M in cash and securities against $16.31M of debt, a net cash position of $243.21M.
Immatics does not currently pay a dividend.
The share price is down 25.9% over the past year. At $7.15 (the Oct 26, 2026 close) it sits near the bottom of its 52-week range of $6.65 to $12.41, below its 200-day moving average of $9.68.
Based on 6 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $17.16, 140.0% above the Oct 26, 2026 close.
Frequently Asked Questions About Immatics
What is the current stock price for IMTX?
As of the Oct 26, 2026 close, IMTX stock trades at $7.15. The 52-week range is $6.65–$12.41, with a day range of $7.03–$7.73.
What is the P/E ratio for IMTX?
The P/E ratio (Price-to-Earnings) for IMTX is shown in the Key Statistics section. This valuation metric helps compare Immatics N.V. to industry peers.
Does IMTX pay dividends?
Immatics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for IMTX?
Based on ratings from 6 professional analysts over the last 90 days, the consensus for IMTX is Buy. The average 12-month price target is $17.16, a 140.0% upside from the Oct 26, 2026 close of $7.15.
What is the market cap of IMTX?
As of the Oct 26, 2026 close, Immatics's market capitalization is $977.3M, classifying it as a small-cap company. Immatics operates in the Healthcare sector within the Biotechnology industry.